Topics:

Medicare Reimbursement

Medicare Reimbursement

Changes to Medicare’s reimbursement plans have inadvertently cut payments to cancer specialists, causing many cancer care centers to lose money and possibly close, according to results of a study commissioned by the Community Oncology Alliance (COA), an advocacy group for oncologists who practice outside of large hospital centers.1

This study investigated the clinical effectiveness and cost-effectiveness of treatments for moderate to severe psoriasis from a managed health care systems perspective. An analysis was conducted of randomized clinical trials evaluating biologic and oral systemic medications and phototherapy for patients with moderate to severe psoriasis.

The 2 physicians who now oversee the FDA want the agency to think of itself less as a regulator and more as a part of the nation’s public health apparatus.

WASHINGTON -- Most Medicare patients will pay .90 more per month in Part B premiums next year -- to .40.

TORONTO -- Two well-accepted adjuvant therapies for early breast cancer proved cost-effective for improving survival, according to a pair of studies.

SPRINGFIELD, Mass. -- Offering hospitals a relatively small financial incentive improved their quality of care for acute myocardial infarction, heart failure, and pneumonia, researchers here reported.

NEW HAVEN, Conn. -- Older Americans are flocking to gastroenterologists to take advantage of Medicare's all-beneficiary coverage of colonoscopy screening, and that's paying off in earlier colon-cancer detection, a study here suggested.

Pages

Subscribe to
Please Wait 20 seconds or click here to close